Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma

被引：0
|
作者：
Shozo Mori
Taku Aoki
Yuhki Sakuraoka
Takayuki Shimizu
Takamune Yamaguchi
Kyung-Hwa Park
Takatsugu Matsumoto
Takayuki Shiraki
Yukihiro Iso
Keiichi Kubota
机构：
[1] Dokkyo Medical University,Department of Gastroenterological Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Pancreatic cancer; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Gemcitabine; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 120
页数：11
相关论文
共 50 条
  • [31] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    MINERVA SURGERY, 2024, : 315 - 325
  • [32] Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
    Salvia, Roberto
    Malleo, Giuseppe
    Maggino, Laura
    Milella, Michele
    Bassi, Claudio
    UPDATES IN SURGERY, 2020, 72 (02) : 321 - 324
  • [33] Outcomes of Margin Status on Survival in Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Therapy
    Swami, Ashish
    Varshney, Vaibhav Kumar
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (06) : 1022 - 1023
  • [34] Adverse events in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line
    Kim, George P.
    Silver, Michelle
    Sanders, Chad
    Cockrum, Paul
    MacEwan, Joanna P.
    Duncan, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
    Silvestris, Nicola
    Longo, Vito
    Cellini, Francesco
    Reni, Michele
    Bittoni, Alessandro
    Cataldo, Ivana
    Partelli, Stefano
    Falconi, Massimo
    Scarpa, Aldo
    Brunetti, Oronzo
    Lorusso, Vito
    Santini, Daniele
    Morganti, Alessio
    Valentini, Vincenzo
    Cascinu, Stefano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 309 - 324
  • [36] Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy
    Kawada, Tomoyuki
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 1071 - 1071
  • [37] Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma
    Timothy E. Newhook
    Jose M. Soliz
    Laura R. Prakash
    Shannon Hancher-Hodges
    Barbra Bryce Speer
    Jonathan A. Wilks
    Naruhiko Ikoma
    Michael P. Kim
    Jeffrey E. Lee
    Matthew H. G. Katz
    Ching-Wei D. Tzeng
    Annals of Surgical Oncology, 2021, 28 : 1563 - 1569
  • [38] Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma
    Newhook, Timothy E.
    Soliz, Jose M.
    Prakash, Laura R.
    Hancher-Hodges, Shannon
    Speer, Barbra Bryce
    Wilks, Jonathan A.
    Ikoma, Naruhiko
    Kim, Michael P.
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1563 - 1569
  • [39] The Impact of Biliary Microbes on Pathological Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
    Shilyansky, Jonathan S.
    Tompkins, Derek
    Steckly, Kelsey
    Cavnar, Michael J.
    Chan, Carlos H.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S140 - S140
  • [40] Impact of Neoadjuvant Chemotherapy and Pretreatment Biliary Drainage for Pancreatic Head Ductal Adenocarcinoma
    Saad Saffo
    Chengwei Peng
    Ronald Salem
    Tamar Taddei
    Anil Nagar
    Digestive Diseases and Sciences, 2022, 67 : 1409 - 1416
12345